IMPACT OF ADJUNCT TREATMENT WITH MAITAKE-SX FRACTION ON GLYCEMIC CONTROL

这个子项目是许多利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 本研究的目的是检验产品Maitake-SX组分将降低2型糖尿病患者的空腹血糖并改善葡萄糖耐量，而对非糖尿病患者无显著影响的假设。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to test the hypothesis that that the product, Maitake-SX fraction, will decrease fasting blood glucose and improve glucose tolerance in patients with type 2 diabetes, without a significant impact on patients without diabetes.